Subscribe

Hartalega Holdings Berhad (5168.KL)

MYR0.97 -0.02 (-1.52%)
MY KLS Basic Materials Chemicals - Specialty
Address C-G-9, Jalan Dataran SD1 52200
Kuala Lumpur, MY
CEO Mun Leong Kuan
IPO 2008-04-17
ISIN MYL5168OO009

Explore sections of this company profile

Description

Hartalega Holdings Berhad operates as an investment holding enterprise with a primary focus on the global manufacturing, distribution, and sale of latex and nitrile gloves. Its extensive market reach spans Malaysia, North America, Europe, various regions of Asia, Australia, South America, and the Middle East. Additionally, the company diversifies its operations through property leasing, pioneering research and development in automation systems, and the international export and trade of medical supplies. Its product offerings cater to a wide array of industries, including healthcare, dentistry, food processing, industrial use, veterinary care, and the spa and beauty salon sectors. The company was established in 1988 and maintains its headquarters in Kuala Lumpur, Malaysia.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
MYR0.97 -0.02 (-1.52%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
14M
Beta
-0.15
Float Shares
1.42B
Free Float %
41.6%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.00% +17.39% +8.00% +50.00% +18.42% +36.36% -31.82% -39.46% -85.83% -32.16% +748.15%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
0.97
DCF (Unlevered) 1.23 +26.6%
DCF (Levered) 0.59 -39.7%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 31% Bullish
Rating 2026-05 Change
Strong Buy 1 0
Buy 4 0
Hold 8 -2
Sell 3 0
Strong Sell 0 0
Quality scores
Altman Z-Score
7.48
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
  • Revenue growth Chemicals - Specialty: +4.7%
    -17.4% Q1'26: -15.7% (vs Q1'25)
  • EPS growth Chemicals - Specialty: +13.2%
    +38.5% Q1'26: +183.3% (vs Q1'25)
  • FCF margin FCF growth · Chemicals - Specialty: +44.1%
    +11.1% Q1'26: +14.4% (vs Q1'25)
  • EBIT margin Chemicals - Specialty: +8.8%
    +5.5% Q1'26: +9.7% (vs Q1'25)
  • ROIC Chemicals - Specialty: +5.6%
    +3.1% Q1'26: +4.9% (vs Q1'25)
  • Share dilution Chemicals - Specialty: +0.1%
    -0.1% Q1'26: -0.3% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×
    0.03× Q1'26: 0.03× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (-0.25) × ERP
WACC = 100% × Ke + 0% × Kd (4.0%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 1.25 Current price: 0.97
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Mar 2015
actual
Mar 2016
actual
Mar 2017
actual
Mar 2018
actual
Mar 2019
actual
Mar 2020
actual
Mar 2021
actual
Mar 2022
actual
Mar 2023
actual
Mar 2024
actual
Mar 2025
actual
Mar 2026
17 Rev. Ana.
17 EPS Ana.
Mar 2027
16 Rev. Ana.
15 EPS Ana.
Mar 2028
10 Rev. Ana.
7 EPS Ana.
Mar 2029
11 Rev. Ana.
10 EPS Ana.
Revenue
1.15B
est: 1.14B (+0.3%)
1.50B
est: 1.50B (-0.1%)
1.82B
est: 1.80B (+1.3%)
2.41B
est: 2.47B (-2.7%)
2.83B
est: 2.89B (-2.0%)
2.92B
est: 3.03B (-3.4%)
6.70B
est: 7.07B (-5.2%)
7.89B
est: 7.96B (-0.9%)
2.41B
est: 2.27B (+6.2%)
1.84B
est: 1.95B (-5.6%)
2.59B
est: 2.56B (+1.0%)
2.24B
2.08B – 2.75B
-12.6% YoY
2.68B
2.24B – 3.11B
+19.6% YoY
2.75B
2.29B – 3.19B
+2.6% YoY
2.91B
2.43B – 3.38B
+5.9% YoY
EBITDA
322.87M
est: 309.42M (+4.3%)
387.89M
est: 406.33M (-4.5%)
420.66M
est: 487.03M (-13.6%)
622.77M
est: 669.90M (-7.0%)
665.43M
est: 781.77M (-14.9%)
691.54M
est: 820.32M (-15.7%)
3.96B
est: 1.91B (+106.7%)
4.79B
est: 2.16B (+122.3%)
-43.79M
est: 614.87M (-107.1%)
178.16M
est: 527.70M (-66.2%)
200.67M
est: 458.70M (-56.3%)
400.77M
371.93M – 493.24M
-12.6% YoY
479.46M
400.57M – 556.74M
+19.6% YoY
492.04M
411.08M – 571.35M
+2.6% YoY
521.29M
435.51M – 605.32M
+5.9% YoY
EBIT
276.99M
est: 255.15M (+8.6%)
317.25M
est: 335.05M (-5.3%)
350.00M
est: 401.60M (-12.8%)
534.35M
est: 552.40M (-3.3%)
561.45M
est: 644.64M (-12.9%)
566.22M
est: 676.43M (-16.3%)
3.82B
est: 1.58B (+141.9%)
4.64B
est: 1.78B (+161.1%)
-206.82M
est: 507.02M (-140.8%)
46.11M
est: 435.14M (-89.4%)
50.01M
est: 308.29M (-83.8%)
269.35M
249.97M – 331.50M
-12.6% YoY
322.24M
269.22M – 374.18M
+19.6% YoY
330.70M
276.28M – 384.00M
+2.6% YoY
350.36M
292.70M – 406.83M
+5.9% YoY
Net Income
209.73M
est: 228.72M (-8.3%)
257.43M
est: 284.76M (-9.6%)
283.00M
est: 297.82M (-5.0%)
438.92M
est: 446.60M (-1.7%)
455.18M
est: 507.15M (-10.2%)
433.62M
est: 467.13M (-7.2%)
2.89B
est: 2.99B (-3.5%)
3.23B
est: 3.28B (-1.3%)
-235.14M
est: 70.00M (-435.9%)
12.50M
est: 43.96M (-71.6%)
74.54M
est: 77.70M (-4.1%)
89.30M
52.63M – 202.78M
+14.9% YoY
154.57M
114.69M – 219.87M
+73.1% YoY
173.53M
136.41M – 209.90M
+12.3% YoY
184.35M
144.91M – 222.98M
+6.2% YoY
SGA
64.66M
est: 71.04M (-9.0%)
85.76M
est: 93.29M (-8.1%)
103.94M
est: 111.81M (-7.0%)
126.89M
est: 153.80M (-17.5%)
139.46M
est: 179.48M (-22.3%)
147.74M
est: 188.33M (-21.6%)
293.66M
est: 439.62M (-33.2%)
225.05M
est: 495.04M (-54.5%)
161.76M
est: 141.17M (+14.6%)
179.39M
est: 121.15M (+48.1%)
191.07M
est: 136.82M (+39.7%)
119.54M
110.94M – 147.12M
-12.6% YoY
143.01M
119.48M – 166.06M
+19.6% YoY
146.77M
122.62M – 170.42M
+2.6% YoY
155.49M
129.91M – 180.55M
+5.9% YoY
EPS
0.07
est: 0.07 (+0.6%)
0.08
est: 0.08 (-5.9%)
0.09
est: 0.09 (-1.2%)
0.13
est: 0.13 (-0.6%)
0.14
est: 0.15 (-5.7%)
0.13
est: 0.14 (-5.0%)
0.84
est: 0.88 (-4.1%)
0.95
est: 0.96 (-1.0%)
-0.07
est: 0.02 (-435.6%)
0.00
est: 0.01 (-71.3%)
0.02
est: 0.02 (-4.3%)
0.03
0.02 – 0.06
+14.9% YoY
0.05
0.03 – 0.06
+73.1% YoY
0.05
0.04 – 0.06
+12.3% YoY
0.05
0.04 – 0.07
+6.2% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-12 B+ 3/5 4/5 3/5 4/5 3/5 1/5 4/5
2026-05-11 B+ 3/5 4/5 3/5 4/5 3/5 1/5 4/5
2026-05-08 B+ 3/5 4/5 3/5 4/5 3/5 1/5 4/5
2026-05-07 B+ 3/5 4/5 3/5 4/5 3/5 1/5 4/5
2026-05-06 B+ 3/5 4/5 3/5 4/5 3/5 1/5 4/5
2026-05-05 A- 4/5 5/5 3/5 4/5 3/5 1/5 4/5
2026-05-04 A- 4/5 5/5 3/5 4/5 3/5 1/5 4/5
2026-04-30 B+ 3/5 5/5 3/5 4/5 2/5 1/5 4/5
2026-04-29 A- 4/5 5/5 3/5 5/5 2/5 1/5 4/5
2026-04-28 A- 4/5 5/5 3/5 5/5 2/5 1/5 4/5
2026-04-27 A- 4/5 5/5 3/5 5/5 2/5 1/5 4/5
2026-04-24 A- 4/5 5/5 3/5 5/5 2/5 1/5 4/5
2026-04-23 A- 4/5 5/5 3/5 5/5 2/5 1/5 4/5
2026-04-22 A- 4/5 5/5 3/5 5/5 2/5 1/5 4/5
2026-04-21 A- 4/5 5/5 3/5 5/5 2/5 1/5 4/5
2026-04-20 A- 4/5 5/5 3/5 5/5 2/5 1/5 4/5
2026-04-17 A- 4/5 5/5 3/5 5/5 2/5 1/5 4/5
2026-04-16 A- 4/5 5/5 3/5 5/5 2/5 1/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-122.77M
OE per share TTM
-0.04
Owner's Yield
-3.16%
Maintenance CapEx ratio
267.78%
Maint CapEx / Avg PPE
73.6%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 50 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF ISFE.L 0.03% 24.3K 0.74%
2 iShares MSCI Emerging Markets Small-Cap ETF EEMS 0.02% 89.5K 0.72%
3 iShares MSCI EM Small Cap UCITS ETF IEMS.L 0.02% 73.4K 0.74%
4 State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L 0.02% 106.3K 0.55%
5 Avantis Emerging Markets Value ETF AVES 0.01% 193.7K 0.36%
6 Avantis Emerging Markets ex-China Equity ETF AVXC 0.01% 52.6K 0.33%
7 Vanguard FTSE All-World ex-US Small-Cap ETF VSS 0.01% 1.71M 0.06%
8 Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L 0.01% 22.7K 0.35%
9 Dimensional - Emerging Markets Value ETF DFEV 0.01% 177.6K 0.46%
10 Dimensional - Emerging Markets ex China Core Equity ETF DEXC 0.01% 26.4K 0.56%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
14.3K
Shares Outstanding
3.41B

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Kam Kuan Executive Chairman 192.0K male
Mun Keng Kuan Chief Business Officer & Executive Director 145.0K male
Mun Leong Kuan Chief Executive Officer & Executive Director 144.0K male
Ming Siang Lee Chief Strategy Officer male
Sheetal Sharma Head of Internal Audit Department female
Siew Fei Yoon Chief Human Resources Officer male
Eu Jin Kuan Chief Operating Officer male
Vin Seung Kuan Chief Corporation Communications Officer male
Fook Chuan Lai Head Scientist of Innovation
Kean Wooi Loh Chief Financial Officer male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits